https://www.thebodypro.com/article/complera-labeling-update-no-longer-recommended-at-
Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate (Complera)News

Complera Labeling Update: No Longer Recommended at High Viral Loads; Hepatotoxicity Precaution Added

    U.S. Food and Drug Administration

    U.S. Food and Drug Administration